कोशिश गोल्ड - मुक्त
Trump’s focus on drug war means big business for defense startups
Mint Mumbai
|December 01, 2025
Drones, sensors and AI platforms developed for other theaters are being rebranded as tools for the fight against ‘narco-terror’
The Trump administration maintains that drug cartels pose an imminent threat to America's national security.
(AP)
The U.S. military has turned its attention southward, and the defense industry is lining up to sell it the tools for a different kind of war.
Defense-tech companies and artificial-intelligence startups have found a vital new market in President Trump's rapidly escalating drug war. Weapons and Al platforms that were designed for a future conflict with China or struggled to prove themselves on the Ukrainian battlefield have found a niche in the administration’s tech-enabled crackdown on drug trafficking.
Drone and imaging companies are assisting the U.S. Coast Guard and Navy with interdiction operations in the Caribbean. AI companies from Silicon Valley to Dubai are pitching platforms that promise to map the hidden networks of fentanyl traffickers. On the southern US. border, a counterdrone system developed in Ukraine is being repurposed to deflect incursions from Mexico.
As Washington has revived the rhetoric and legal tools of the global war on terror, more companies large and small have staked their claims to the emerging market, at times retooling to fit the latest mission. They have rebranded their drones, sensors, Al tools and data platforms as custom tools for Trump’s fight against “narco-terror.”
The effort has accelerated since early September, when the U.S. military began an unprecedented campaign against small drug-trafficking vessels, executing strikes that have killed more than 80 people. Some regional allies have accused the U.S. of extrajudicial killings of civilians. The Trump administration maintains that drug cartels pose an imminent threat to America’s national security.
यह कहानी Mint Mumbai के December 01, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Mumbai से और कहानियाँ
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

